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Abstract Despite the central role that antibodies play in the adaptive immune system and in
biotechnology, much remains unknown about the quantitative relationship between an antibody’s
amino acid sequence and its antigen binding affinity. Here we describe a new experimental
approach, called Tite-Seq, that is capable of measuring binding titration curves and corresponding
affinities for thousands of variant antibodies in parallel. The measurement of titration curves
eliminates the confounding effects of antibody expression and stability that arise in standard deep
mutational scanning assays. We demonstrate Tite-Seq on the CDR1H and CDR3H regions of a well-
studied scFv antibody. Our data shed light on the structural basis for antigen binding affinity and
suggests a role for secondary CDR loops in establishing antibody stability. Tite-Seq fills a large gap
in the ability to measure critical aspects of the adaptive immune system, and can be readily used
for studying sequence-affinity landscapes in other protein systems.
DOI: 10.7554/eLife.23156.001
Introduction
During an infection, the immune system must recognize and neutralize invading pathogens. B-cells
contribute to immune defense by producing antibodies, proteins that bind specifically to foreign
antigens. The astonishing capability of antibodies to recognize virtually any foreign molecule has
been repurposed by scientists in a wide variety of experimental techniques (immunofluorescence,
western blots, ELISA, ChIP-Seq, etc.). Antibody-based therapeutic drugs have also been developed
for treating many different diseases, including cancer (Chan and Carter, 2010).
Much is known about the qualitative mechanisms of antibody generation and function
(Murphy et al., 2008). The antigenic specificity of antibodies in humans, mice, and most jawed ver-
tebrates is primarily governed by six complementarity determining regions (CDRs), each roughly 10
amino acids (aa) long. Three CDRs (denoted CDR1H, CDR2H, and CDR3H) are located on the anti-
body heavy chain, and three are on the light chain. During B-cell differentiation, these six sequences
are randomized through V(D)J recombination, then selected for functionality as well as against the
ability to recognize host antigens. Upon participation in an immune response, CDR regions can fur-
ther undergo somatic hypermutation and selection, yielding higher-affinity antibodies for specific
antigens. Among the CDRs, CDR3H is the most highly variable and typically contributes the most to
antigen specificity; less clear are the functional roles of the other CDRs, which often do not interact
with the target antigen directly.
Many high-throughput techniques, including phage display (Smith, 1985; Vaughan et al., 1996;
Schirrmann et al., 2011), ribosome display (Fujino et al., 2012), yeast display (Boder and Wittrup,
1997; Gai and Wittrup, 2007), and mammalian cell display (Forsyth et al., 2013), have been
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developed for optimizing antibodies ex vivo. Advances in DNA sequencing technology have also
made it possible to effectively monitor both antibody and T-cell receptor diversity within immune
repertoires, e.g. in healthy individuals (Boyd et al., 2009; Weinstein et al., 2009; Robins et al.,
2009, 2010; Mora et al., 2010; Venturi et al., 2011; Murugan et al., 2012; Zvyagin et al., 2014;
Elhanati et al., 2014; Qi et al., 2014; Thomas et al., 2014; Elhanati et al., 2015), in specific tissues
(Madi et al., 2014), in individuals with diseases (Parameswaran et al., 2013) or following vaccina-
tion (Jiang et al., 2013; Vollmers et al., 2013; Laserson et al., 2014; Galson et al., 2014;
Wang et al., 2015). Yet many questions remain about basic aspects of the quantitative relationship
between antibody sequence and antigen binding affinity. How many different antibodies will bind a
given antigen with specified affinity? How large of a role do epistatic interactions between amino
acid positions within the CDRs have on antigen binding affinity? How is this sequence-affinity land-
scape navigated by the V(D)J recombination process, or by somatic hypermutation? Answering these
and related questions is likely to prove critical for developing a systems-level understanding of the
adaptive immune system, as well as for using antibody repertoire sequencing to diagnose and moni-
tor disease.
Recently developed ‘deep mutational scanning’ (DMS) assays (Fowler and Fields, 2014) provide
one potential method for measuring binding affinities with high enough throughput to effectively
explore antibody sequence-affinity landscapes. In DMS experiments, one begins with a library of var-
iants of a specific protein. Proteins that have high levels of a particular activity of interest are then
enriched via one or more rounds of selection, which can be carried out in a variety of ways. The set
of enriched sequences is then compared to the initial library, and protein sequences (or mutations
within these sequences) are scored according to how much this enrichment procedure increases
their prevalence.
eLife digest Antibodies are proteins produced by cells of the immune system to tag or
neutralize potential threats to the body, such as foreign substances and disease-causing microbes.
Antibodies do this by binding to target molecules called antigens. An antibody’s ability to bind to
an antigen depends on the sequence of amino acids – the building blocks of proteins – that make
up the antibody. Through a process that randomizes this sequence of amino acids, the immune
system generates a vast pool of antibodies that are able to target almost any foreign antigen that
exists in nature.
Currently, little is understood about how the sequence of amino acids in an antibody determines
how strongly that antibody binds to its antigen target – a property referred to as the antibody’s
binding affinity. Answering this fundamental question requires techniques that can measure the
affinities of many different antibodies at the same time. However, previous high-throughput
methods have been unable to provide quantitative measurements of binding affinities. These kinds
of measurements are difficult because an antibody’s amino acid sequence governs more than just
binding affinity: it also affects how easy it is to produce that antibody, and what fraction of antibody
molecules work properly.
Adams et al. now describe a new method, named “Tite-Seq”, that overcomes these issues. First,
thousands of different antibodies are displayed on the surface of yeast cells, with each cell carrying a
single kind of antibody. These cells are then incubated with fluorescently labeled antigen at a wide
range of different concentrations. Next, the yeast cells are sorted based on how brightly they glow;
brighter cells have more antigen bound to them, and so it is possible to calculate how much of the
antigen is bound to each kind of antibody at each concentration. Plotting these data provides a
“binding curve” for each antibody, which is then used to read off the antibody’s binding affinity in a
way that is not affected by the factors that have plagued other high-throughput methods.
Tite-Seq is thus able to measure the binding affinities for thousands of different antibodies at the
same time. This will potentially allow researchers to address many fundamental and yet unanswered
questions about how the immune system works. Tite-Seq can also be used to measure how amino
acid sequence affects the binding affinity of proteins other than antibodies.
DOI: 10.7554/eLife.23156.002
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Multiple DMS assays have been described for investigating protein-ligand binding affinity. But no
DMS assay has yet been shown to provide absolute quantitative binding affinity measurements, i.e.,
dissociation constants in molar units. For example, one of the first DMS experiments (Fowler et al.,
2010) used phage display technology to measure how mutations in a WW domain affect the affinity
of this domain for its peptide ligand. These data were sufficient to compute enrichment ratios and
corresponding sequence logos, but they did not yield quantitative affinities. Analogous experiments
have since been performed on antibodies using yeast display (Reich et al., 2015; Kowalsky et al.,
2015) and mammalian cell display (Forsyth et al., 2013). Yeast-display-based DMS assays have also
proven particularly useful for mapping protein epitopes that are targeted by specific antibodies of
interest (Kowalsky et al., 2015; Doolan and Colby, 2015; Van Blarcom et al., 2015). Still, none of
these approaches provides quantitative affinity values. SORTCERY (Reich et al., 2015, ), a DMS
assay that combines yeast display and quantitative modeling, has been shown to provide approxi-
mate rank-order values for the affinity of a specific protein for short unstructured peptides of varying
sequence. Determining quantitative affinities from SORTCERY data, however, requires separate low-
throughput calibration measurements (Reich et al., 2014). Moreover, it is unclear how well SORT-
CERY, if applied to a library of folded proteins rather than unstructured peptides, can distinguish
sequence-dependence effects on affinity from sequence-dependent effects on protein expression
and stability. Other recent work has described a DMS assay, again based on yeast display, for mea-
suring fold-changes in affinity relative to a reference protein (Kowalsky and Whitehead, 2016). This
method, however, does not provide absolute values for dissociation constants, is vulnerable to the
confounding effects of sequence-dependent expression and protein stability, and was observed to
have only a 10-fold dynamic range.
To enable massively parallel measurements of absolute binding affinities for antibodies and other
structured proteins, we have developed an assay called ‘Tite-Seq.’ Tite-Seq, like SORTCERY, builds
on the capabilities of Sort-Seq, an experimental strategy that was first developed for studying tran-
scriptional regulatory sequences in bacteria (Kinney et al., 2010). Sort-Seq combines fluorescence-
activated cell sorting (FACS) with high-throughput sequencing to provide massively parallel meas-
urements of cellular fluorescence. In the Tite-Seq assay, Sort-Seq is applied to antibodies displayed
on the surface of yeast cells and incubated with antigen at a wide range of concentrations. From the
resulting sequence data, thousands of antibody-antigen binding titration curves and their corre-
sponding absolute dissociation constants (here denoted KD) can be inferred. By assaying full binding
curves, Tite-Seq is able to measure affinities over many orders of magnitude (We note that
Kowalsky et al. (2015) have described yeast display DMS experiments performed at multiple con-
centrations. These data, however, were not used to reconstruct titration curves or infer quantitative
KD values). Moreover, the resulting affinity values provided by Tite-Seq are not confounded by the
(rather substantial) effect that sequence variation can have on either (a) the amount of protein
expressed on the surface of cells or (b) the specific activity of displayed proteins (i.e., the fraction of
protein molecules that are functional).
We demonstrated Tite-Seq on a protein library derived from a well-studied single-chain variable
fragment (scFv) antibody specific to the small molecule fluorescein (Boder and Wittrup, 1997;
Boder et al., 2000). Mutations were restricted to CDR1H and CDR3H regions, which are known to
play an important role in the antigen recognition of this scFv (Boder et al., 2000; Midelfort et al.,
2004). The resulting affinity measurements were validated with binding curves for a handful of
clones measured using standard low-throughput flow cytometry. Our Tite-Seq measurements reveal
both expected and unexpected differences between the effects of mutations in CDR1H and CDR3H.
These data also shed light on structural aspects of antigen recognition that are independent of
effects on antibody stability.
Results
Overview of Tite-Seq
Our general strategy is illustrated in Figure 1. First, a library of variant antibodies is displayed on the
surface of yeast cells (Figure 1A). The composition of this library is such that each cell displays a sin-
gle antibody variant, and each variant is expressed on the surface of multiple cells. Cells are then
incubated with the antigen of interest, bound antigen is fluorescently labeled, and fluorescence-
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activated cell sorting (FACS) is used to sort cells one-by-one into multiple ‘bins’ based on this fluo-
rescent readout (Figure 1B). Deep sequencing is then used to survey the antibody variants present
in each bin. Because each variant antibody is sorted multiple times, it will be associated with a histo-
gram of counts spread across one or more bins (Figure 1C). The spread in each histogram is due to
cell-to-cell variability in antibody expression, and to the inherent noisiness of flow cytometry meas-
urements. Finally, the histogram corresponding to each antibody variant is used to compute an
‘average bin number’ (Figure 1C, dots), which serves as a proxy measurement for the average
amount of bound antigen per cell.
It has previously been shown that KD values can be accurately measured using yeast-displayed
antibodies by taking binding titration curves, i.e., by measuring the average amount of bound
Figure 1. Schematic illustration of Tite-Seq. (A) A library of variant antibodies (various colors) are displayed on the
surface of yeast cells (tan). (B) The library is exposed to antigen (green triangles) at a defined concentration, cell-
bound antigen is fluorescently labeled, and FACS is used to sort cells into bins according to measured
fluorescence. (C) The antibody variants in each bin are sequenced and the distribution of each variant across bins
is computed (histograms; colors correspond to specific variants). The mean bin number (dot) is then used to
quantify the typical amount of bound antigen per cell. (D) Binding titration curves (solid lines) and corresponding
KD values (vertical lines) can be inferred for individual antibody sequences by using the mean fluorescence values
(dots) obtained from flow cytometry experiments performed on clonal populations of antibody-displaying yeast.
(E) Tite-Seq consists of performing the Sort-Seq experiment in panels A–C at multiple antigen concentrations,
then inferring binding curves using mean bin number as a proxy for mean cellular fluorescence. This enables KD
measurements for thousands of variant antibodies in parallel. We note that the Tite-Seq results illustrated in panel
E were simulated using three bins under idealized experimental conditions, as described in Appendix 1. The
inference of binding curves from real Tite-Seq data is more involved than this panel might suggest, due to the
multiple sources of experimental noise that must be accounted for.
DOI: 10.7554/eLife.23156.003
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antigen as a function of antigen concentration (VanAntwerp and Wittrup, 2000; Gai and Wittrup,
2007). The median fluorescence f of labeled cells is expected to be related to antigen concentration
via
f ¼ A c
cþKDþB (1)
where A is proportional to the number of functional antibodies displayed on the cell surface, B
accounts for background fluorescence, and c is the concentration of free antigen in solution.
Figure 1D illustrates the shape of curves having this form. By using flow cytometry to measure f on
clonal populations of yeast at different antigen concentrations c, one can infer curves having the sig-
moidal form shown in Equation 1 and thereby learn KD. Such measurements, however, can only be
performed in a low-throughput manner.
Tite-Seq allows thousands of binding titration curves to be measured in parallel. The Sort-Seq
procedure illustrated in Figure 1A–C is performed at multiple antigen concentrations, and the
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Figure 2. Yeast display construct and antibody libraries (A) Co-crystal structure of the 4-4-20 (WT) antibody from
Whitlow et al. (1995) (PDB code 1FLR). The CDR1H and CDR3H regions are colored blue and red, respectively.
(B) The yeast display scFv construct from Boder and Wittrup (1997) that was used in this study. Antibody-bound
antigen (fluorescein) was visualized using PE dye. The amount of surface-expressed protein was separately
visualized using BV dye. Approximate location of the CDR1H (blue) and CDR3H (red) regions within the scFv are
illustrated. (C) The gene coding for this scFv construct, with the six CDR regions indicated. The WT sequence of
the two 10 aa variable regions are also shown. (D) The number of 1-, 2-, and 3-codon variants present in the 1H
and 3H scFv libraries. Figure 2—figure supplement 1 shows the cloning vector used to construct the CDR1H and
CDR3H libraries, as well as the form of the resulting expression plasmids.
DOI: 10.7554/eLife.23156.004
The following figure supplement is available for figure 2:
Figure supplement 1. Cloning strategy.
DOI: 10.7554/eLife.23156.005
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resulting average bin number for each variant antibody is plotted against concentration. Sigmoidal
curves are then fit to these proxy measurements, enabling KD values to be inferred for each variant.
We emphasize that KD values cannot, in general, be accurately inferred from Sort-Seq experi-
ments performed at a single antigen concentration. Because the relationship between binding and
KD is sigmoidal, the amount of bound antigen provides a quantitative readout of KD only when the
concentration of antigen used in the labeling procedure is comparable in magnitude to KD. How-
ever, single mutations within a protein binding domain often change KD by multiple orders of magni-
tude. Sort-Seq experiments used to measure sequence-affinity landscapes must therefore be carried
out over a range of concentrations large enough to encompass this variation.
Furthermore, as illustrated in Figure 1C and D, different antibody variants often lead to different
levels of functional antibody expression on the yeast cell surface. If one performs Sort-Seq at a single
antigen concentration, high affinity (low KD) variants with low expression (blue variant) may bind less
antigen than low affinity (high KD) variants with high expression (orange variant). Only by measuring
full titration curves can the effect that sequence has on affinity be deconvolved from sequence-
dependent effects on functional protein expression.
Proof-of-principle Tite-Seq experiments
To test the feasibility of Tite-Seq, we used a well-characterized antibody-antigen system: the 4-4-20
single chain variable fragment (scFv) antibody (Boder and Wittrup, 1997), which binds the small
molecule fluorescein with KD ¼ 1:2 nM (Gai and Wittrup, 2007). This system was used in early work
to establish the capabilities of yeast display (Boder and Wittrup, 1997), and a high resolution co-
crystal structure of the 4-4-20 antibody bound to fluorescein, shown in Figure 2A, has been deter-
mined (Whitlow et al., 1995). An ultra-high-affinity (KD ¼ 270 fM) variant of this scFv, called 4m5.3,
has also been found (Boder et al., 2000). In what follows, we refer to the 4-4-20 scFv from
Boder and Wittrup (1997) as WT, and the 4m5.3 variant from Boder et al. (2000) as OPT.
The scFv was expressed on the surface of yeast as part of the multi-domain construct illustrated
in Figure 2B and previously described in Boder and Wittrup (1997). Following (Boder et al., 2000),
we used fluorescein-biotin as the antigen and labeled scFv-bound antigen with streptavidin-RPE
(PE). The amount of surface-expressed protein was separately quantified by labeling the C-terminal
c-Myc tag using anti-c-Myc primary antibodies, followed by secondary antibodies conjugated to Bril-
liant Violet 421 (BV). See Appendix 2 for details on this labeling procedure.
Two different scFv libraries were assayed simultaneously. In the ‘1H’ library, a 10 aa region
encompasing the CDR1H region of the WT scFv (see Figure 2C) was mutagenized using microarray-
synthesized oligos (see Appendix 3 for details). The resulting 1H library consisted of all 600 single-
codon variants of this 10 aa region, 1100 randomly chosen 2-codon variants, and 150 random 3-
codon variants (Figure 2D). An analogous ‘3H’ library was generated for a 10 aa region containing
the CDR3H region of this scFv. In all of the Tite-Seq experiments described below, these two librar-
ies were pooled together and supplemented with WT and OPT scFvs, as well with a nonfunctional
scFv referred to as D.
Tite-Seq was carried out as follows. Yeast cells expressing scFv from the mixed library were incu-
bated with fluorescein-biotin at one of eleven concentrations: 0 M, 10 9:5 M, 10 9 M, 10 8:5 M, 10 8
M, 10 7:5 M, 10 7 M, 10 6:5 M, 10 6 M, 10 5:5 M, and 10 5 M. After subsequent PE labeling of bound
antigen, cells were sorted into four bins using FACS (Figure 3A). Separately, BV-labeled cells were
sorted according to measured scFv expression levels (Figure 3B). The number of cells sorted into
each bin is shown in Figure 3C. Each bin of cells was regrown and bulk DNA was extracted. The 1H
and 3H variable regions were then PCR amplified and sequenced using paired-end Illumina sequenc-
ing, as described in Appendix 4. The final data set consisted of an average of 2:6 106 sequences
per bin across all 48 bins (Figure 3D). Three independent replicates of this experiment were per-
formed on three different days.
For each variant scFv gene, a KD value was inferred by fitting a binding curve to the resulting
Tite-Seq data, with separate curves independently fit to data from each Tite-Seq experiment
(Figure 4A). As illustrated in Figure 1E, this fitting procedure uses the sigmoidal function in Equa-
tion 1 to model mean bin number as a function of antigen concentration. However, the need to
account for multiple sources of noise in the Tite-Seq experiment necessitates a more complex
Adams et al. eLife 2016;5:e23156. DOI: 10.7554/eLife.23156 6 of 27
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procedure than Figure 1E might suggest; the details of this inference procedure are described in
Appendix 5.
Separately, the Sort-Seq data obtained by sorting the BV-labeled libraries were used to deter-
mine the expression level of each scFv. Specifically, we use E to denote (for each scFv in the library)
Figure 3. Details of our Tite-Seq experiments. (A) Gates used to sort cells based on PE fluorescence, which
provides a readout of bound antigen. Cells were labeled at the eleven different antigen concentrations. Shades of
red indicate the four fluorescence gates used to sort cells; these correspond to bins 0, 1, 2, and 3 (from left to
right). (B) Gates, indicated in shades of purple, used to sort cells based on BV fluorescence, which provides a
readout of antibody expression. (C) The number of cells sorted into each bin. (D) The number of Illumina reads
obtained from each bin of sorted cells after quality control measures were applied. The data shown in this figure
corresponds to a single Tite-Seq experiment. Figure 3—figure supplement 1 and Figure 3—figure supplement
2 show data for two independent replicates of this experiment.
DOI: 10.7554/eLife.23156.006
The following figure supplements are available for figure 3:
Figure supplement 1. Tite-Seq experiment, replicate 2.
DOI: 10.7554/eLife.23156.007
Figure supplement 2. Tite-Seq experiment, replicate 3.
DOI: 10.7554/eLife.23156.008
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Figure 4. Accuracy and precision of Tite-Seq. (A) Binding curves and KD measurements inferred from Tite-Seq
data. (B) Mean fluorescence values (dots) and corresponding inferred binding curves (lines) obtained by flow
cytometry measurements for five selected scFvs (WT, OPT, C5, C45, and C107). In (A,B), values corresponding to 0
M fluorescein are plotted on the left-most edge of the plot, dotted lines show the upper (10 5 M) and lower (10 9:5
M) limits on KD sensitivity, vertical lines show inferred KD values, and different shades correspond to different
replicate experiments. (C) Comparison of the Tite-Seq-measured and flow-cytometry-measured KD values for all
clones tested. Colors indicate different scFv protein sequences as follows: WT (purple), OPT (green), D (black), 1H
clones (blue), and 3H clones (red). Each KD value indicates the mean log10 KD value obtained across all replicates,
with error bars indicating standard error. Clones with KD outside of the affinity range are drawn on the boundaries
of this range, which are indicated with dotted lines. The coefficient of determination (R2) between log Tite-Seq
values and log flow KDvalues includes clones outside of the affinity range; in such cases, the corresponding
boundary value (10 9:5 M or 10 5:0 M) has been used. The amino acid sequences and measured KD values for all
clones tested are provided in Table 1. Figure 4—figure supplement 1 provides plots, analogous to panels A and
B, for all of the assayed clones. Figure 4—figure supplement 2 compares KD and E values obtained across all
three Tite-Seq replicates. Figure 4—figure supplement 3 quantifies measurement error using synonymous
mutants. Figure 4—figure supplement 4 provides information about library composition. Figure 4—figure
supplement 5 illustrates the poor correlation between scFv enrichment and Tite-seq measured KD values.
Figure 4 continued on next page
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the mean bin number that results from this expression-based sorting; this E value provides a mea-
surement of the surface expression level of that scFv. All E values have been scaled so that the mean
of such measurements for all synonymous WT scFv gene variants is 1.0.
Low-throughput validation experiments
To judge the accuracy of Tite-Seq, we separately measured binding curves for individual scFv clones
as described for Figure 1D. In addition to the WT, OPT, and D scFvs, we assayed eight clones from
the 1H library (named C3, C5, C7, C18, C22, C132, C133 and C144) and eight clones from the 3H
library (C39, C45, C93, C94, C102, C103, C107, C112). Each clone underwent the same labeling pro-
cedure as in the Tite-Seq experiment, after which median fluorescence values were measured using
standard flow cytometry. KD values were then inferred by fitting binding curves of the form in Equa-
tion 1 using the procedure described in Appendix 6. These curves, which can be directly compared
to Tite-Seq measurements (Figure 4A), are plotted in Figure 4B; at least three replicate binding
curves were measured for each clone. See Figure 4—figure supplement 1 for the titration curves of
all the tested clones.
Tite-Seq can measure dissociation constants
Figure 4C reveals a strong correspondence between the KD values measured by Tite-Seq and those
measured using low-throughput flow cytometry. The robustness of Tite-Seq is further illustrated by
the consistency of KD values measured for the WT scFv. Using Tite-Seq, and averaging the results
from the 33 synonymous variants and over all three replicates, we determined KD ¼ 10 8:870:02 M for
the WT scFv. These measurements are largely consistent with the measurement of KD ¼ 10 8:610:07
M obtained by averaging low-throughput flow cytometry measurements across 10 replicates, and
coincides with the previously measured value of 1:2 nM ¼ 10 8:9 M reported in (Gai and Wittrup,
2007). The three independent replicate Tite-Seq experiments give reproducible results as measured
by direct comparison (Figure 4—figure supplement 2), from synonymous mutant variation (Fig-
ure 4—figure supplement 3) and library composition Figure 4—figure supplement 4) with Pearson
coefficients ranging from r ¼ 0:82 to r ¼ 0:89 for all the measured KD values between replicates;
note that KD values outside of the sensitivity range are included in the calculation of these Pearson
coefficients as described in the Figure 4 caption.
The error bars for KD values in Figure 4C calculated from the variability of the fits to different rep-
licates therefore support the reproducibility of the experiment. The main discrepancy in these error
Figure 4 continued
Figure 4—figure supplement 6 shows a 2-fold difference in the specific activities of OPT and WT scFvs.
Figure 4—figure supplement 7 illustrates the simulations we used in Figure 4—figure supplement 8 to validate
the ability of our analysis to infer correct KD values.
DOI: 10.7554/eLife.23156.009
The following figure supplements are available for figure 4:
Figure supplement 1. Binding curves for all clones.
DOI: 10.7554/eLife.23156.010
Figure supplement 2. Concordance between replicate experiments.
DOI: 10.7554/eLife.23156.011
Figure supplement 3. Error estimates from synonymous mutants.
DOI: 10.7554/eLife.23156.012
Figure supplement 4. Composition of scFv libraries.
DOI: 10.7554/eLife.23156.013
Figure supplement 5. Sort-Seq enrichment correlates poorly with Tite-Seq-measured affinity.
DOI: 10.7554/eLife.23156.014
Figure supplement 6. Differing specific activities of OPT and WT.
DOI: 10.7554/eLife.23156.015
Figure supplement 7. Realistic Tite-Seq simulations.
DOI: 10.7554/eLife.23156.016
Figure supplement 8. Validation of analysis pipeline.
DOI: 10.7554/eLife.23156.017
Adams et al. eLife 2016;5:e23156. DOI: 10.7554/eLife.23156 9 of 27
Research article Biophysics and Structural Biology
bar calculations occurred for clones c22 and c102 (see also Figure 4—figure supplement 1). The
reason for this discrepancy is currently unclear. We note that Tite-Seq-measured KD values for these
two clones are close to 10 7 M, and that the analysis of synonymous variants (Figure 4—figure sup-
plement 3) found that Tite-Seq-measured KDs in this region exhibited the largest variations.
The necessity of performing KD measurements over a wide range of antigen concentrations is
illustrated in Figure 4—figure supplement 5. At each antigen concentration used in our Tite-Seq
experiments, the enrichment of scFvs in the high-PE bins correlated poorly with the KD values
inferred from full titration curves. Moreover, at each antigen concentration used, a detectable corre-
lation between KD and enrichment was found only for scFvs with KD values close to that
concentration.
Figure 4—figure supplement 6 suggests a possible reason for the weak correlation between KD
values and enrichment in high-PE bins. We found that, at saturating concentrations of fluorescein
(2M), cells expressing the OPT scFv bound twice as much fluorescein as cells expressing the WT
scFv. This difference was not due to variation in the total amount of displayed scFv, which one might
control for by labeling the c-Myc epitope as in Reich et al. (2015). Rather, this difference in binding
reflects a difference in the specific activity of displayed scFvs. Yeast display experiments performed
at a single antigen concentration cannot distinguish such differences in specific activity from differen-
ces in scFv affinity.
To further test the capability of Tite-Seq to infer dissociation constants from sequencing data
over a wide range of values, as well as to validate our analysis procedures, we simulated Tite-Seq
Table 1. Clones measured using flow cytometry and Tite-Seq. List of scFv clones, ordered by their flow-cytometry-measured KD values.
With the exception of OPT and D, these clones differed from WT only in their 1H and 3H variable regions. WT amino acids within these
regions are capitalized; variant amino acids are shown in lower case. No sequence is shown for D because this clone contained a large
deletion, making identification of the 1H and 3H variable regions meaningless. KD values saturating our lower detection limit of 10
 9:5
M or upper detection limit of 10 5:0M are written with a <
~
or >
~
sign to emphasize the uncertainty in these measurements. Tite-Seq
KD values indicate mean and standard errors computed across the three replicate Tite-Seq experiments; they are not averaged across
synonymous variants.
Name 1H variable region
3H
variable region No. replicates (flow) KD [M] (flow) KD [M] (Tite-Seq)
OPT TFghYWMNWV GasYGMeYlG 3 <
~
10 9.5 <
~
10 9.5
C107 TFSDYWMNWV GaYYGMDYWG 3 10 9.28±0.04 10 9.18±0.11
C112 TFSDYWMNWV GSYYGMDYcG 3 10 8.95±0.07 10 9.19±0.14
WT TFSDYWMNWV GSYYGMDYWG 10 10 8.61±0.07 10 8.92±0.10
C144 vFSDYWMNWV GSYYGMDYWG 3 10 8.57±0.03 10 8.86±0.04
C133 aFSDYWMNWV GSYYGMDYWG 3 10 8.55±0.06 10 8.62±0.09
C132 TFmDYWlNWV GSYYGMDYWG 3 10 8.48±0.08 10 8.38±0.29
C94 TFSDYWMNWV GSYYGMDsWG 3 10 8.46±0.06 10 8.50±0.04
C5 TFSDYWiNWV GSYYGMDYWG 3 10 8.34±0.10 10 8.55±0.09
C93 TFSDYWMNWV GSYrGMDYWG 3 10 7.35±0.08 10 7.60±0.70
C39 TFSDYWMNWV GSYYGMDYWa 3 10 7.08±0.20 10 7.28±0.17
C102 TFSDYWMNWV sSkYGMDYWG 3 10 5.76±0.16 10 7.25±0.60
C22 ssSDYWMNWV GSYYGMDYWG 3 10 5.69±0.31 10 7.53±0.07
C7 hFSDYWMNWl GSYYGMDYWG 3 10 5.53±0.18 10 5.39±0.18
C45 TFSDYWMNWV GSYdGnDYWG 3 10 5.40±0.24 >
~
10 5.0
C103 TFSDYWMNWV GSYYGMDlWG 3 10 5.15±0.47 10 5.44±0.55
C3 TFSDYWMsWV GSYYGMDYWG 3 >
~
10 5.0 >
~
10 5.0
C18 TFSDYsMNWV GSYYGMDYWG 3 >
~
10 5.0 >
~
10 5.0
D – – 12 >
~
10 5.0 >
~
10 5.0
DOI: 10.7554/eLife.23156.018
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data in silico and analyzed the results using the same analysis pipeline that we used for our experi-
ments. Details about the simulations are given in Appendix 7. The simulated data is illustrated in Fig-
ure 4—figure supplement 7. KD values inferred from these simulated data agreed to high accuracy
with the KD used in the simulation (Figure 4—figure supplement 8), thus validating our analysis
pipeline.
Properties of the affinity and expression landscapes
Figure 5 shows the effect that every single-amino-acid substitution mutation within the 1H and 3H
variable regions has on affinity and on expression; histograms of these effects are provided in Fig-
ure 5—figure supplement 1. In both regions, the large majority of mutations weaken antigen bind-
ing (1H: 88%; 3H: 93%), with many mutations increasing KD above our detection threshold of 10
 5 M
(1H: 36%; 3H: 52%). Far fewer mutations reduced KD (1H: 12%; 3H: 7%), and very few dropped KD
below our detection limit of 10 9:5 M (1H: 0%; 3H: 3%). Histograms of the effect of two or three
Figure 5. Effects of substitution mutations on affinity and expression. Heatmaps show the measured effects on
affinity (A,B) and expression (C,D) of all single amino acid substitutions within the variables regions of the 1H (A,C)
and 3H (B,D) libraries. Purple dots indicate residues of the WT scFv. Green dots indicate non-WT residues in the
OPT scFv. Figure 5—figure supplement 1 provides histograms of the non-WT values displayed in panels A–D.
Figure 5—figure supplement 2 compares the effects on KD of both single-point and multi-point mutations.
DOI: 10.7554/eLife.23156.020
The following figure supplements are available for figure 5:
Figure supplement 1. Histograms of substitution effects on affinity and expression.
DOI: 10.7554/eLife.23156.021
Figure supplement 2. Effects of multi-point mutations on affinity and expression.
DOI: 10.7554/eLife.23156.022
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amino acid changes relative to WT, shown in Figure 5—figure supplement 2A, reveal that multiple
random mutations tend to further reduce affinity. We also observed that mutations within the 3H
variable region have a larger effect on affinity than do mutations in the 1H variable region. Specifi-
cally, single amino acid mutations in 3H were seen to increased KD more than mutations in 1H (1H
median KD ¼ 10 6:84; 3H median KD >~ 10 5:0; P ¼ 4:7 10 4, one-sided Mann-Whitney U test). This
result suggests that binding affinity is more sensitive to variation in CDR3H than to variation in
CDR1H, a finding that is consistent with the conventional understanding of these antibody CDR
regions (Xu and Davis, 2000; Liberman et al., 2013).
Our observations are thus fully consistent with the hypothesis that the amino acid sequences of
the CDR1H and CDR3H regions of the WT scFv have been selected for high affinity binding to fluo-
rescein. We know this to be true, of course; still, this result provides an important validation of our
Tite-Seq measurements.
To further validate our Tite-Seq affinity measurements, we examined positions in the high affinity
OPT scFv (from [Boder et al., 2000]) that differ from WT and that lie within the 1H and 3H variable
regions. As illustrated in Figure 5A and B, five of the six OPT-specific mutations reduce KD or are
nearly neutral. Previous structural analysis (Midelfort et al., 2004) has suggested that D106E, the
only OPT mutation that we find significantly increases KD, may indeed disrupt antigen binding on its
own while still increasing affinity in the presence of the S101A mutation.
Next, we used our measurements to build a ‘matrix model’ (also known as a ‘position-specific
affinity matrix,’ or PSAM [Foat et al., 2006]) describing the sequence-affinity landscape of these two
regions. Our model assumed that the log10 KD value for an arbitrary amino acid sequence could be
computed from the log10 KD value of the WT scFv, plus the measured change in log10 KD produced
by each amino acid substitution away from WT. We evaluated our matrix models on the 1H and 3H
variable regions of OPT, finding an affinity of 10 9:16 M. Our simple model for the sequence affinity
landscape of this scFv therefore correctly predicts that OPT has higher affinity than WT. The quanti-
tative affinity predicted by our model does not match the known affinity of the OPT scFv
(KD ¼ 10 12:6 M), but this is unsurprising for three reasons. First the OPT scFv differs from WT in 14
residues, only 6 of which are inside the 1H and 3H variable regions assayed here. Second, one of the
OPT mutations (W108L) reduces KD below our detection threshold of 10
 9:5 M; in building our matrix
model, we set this value equal to 10 9:5, knowing it would likely underestimate the affinity-increasing
effect of the mutation. Third, our additive model ignores potential epistatic interactions. Still, we
thought it worth asking how likely it it would be for six random mutations within the 1H and 3H vari-
able regions to reduce affinity as much as our model predicts for OPT. We therefore simulated a
large number (107) of variants having a total of 6 substitution mutations randomly scattered across
the 1H and 3H variable regions. The fraction of these random sequences that had an affinity at or
below our predicted affinity for OPT was 4:7 10 5. This finding is fully consistent with the fact that
the mutations in OPT relative to WT were selected for increased affinity, an additional confirmation
of the validity of our Tite-Seq measurements.
The sequence-expression landscape measured in our separate Sort-Seq experiment yielded quali-
tatively different results (Figure 5C and D). We observed no significant difference in the median
effect that mutations in the variable regions of 1H (median E ¼ 0:826) versus 3H (median E ¼ 0:822)
have on expression (P ¼ 0:96, two-sided Mann-Whitney U test); see also Figure 5—figure supple-
ment 1. The variance in these effects, however, was larger in 3H than in 1H (P ¼ 9:9 10 16, Lev-
ene’s test). These results suggest two things. First, the 3H variable region appears to have a larger
effect on scFv expression than the 1H variable region has. At the same time, since we observe fewer
beneficial mutations in 1H (Figure 5C) than in 3H (Figure 5D), the WT sequence appears to be more
highly optimized for expression in CDR1H than in CDR3H. The effect of double or triple mutations
further reduced expression in both CDRs (Figure 5—figure supplement 2B), similar to what was
observed for affinity.
Structural correlates of the sequence-affinity landscape
We asked if the sensitivity of the antibody to mutations could be understood from a structural per-
spective. To quantify sensitivity of affinity and expression at each position i, we computed two
quantities:
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SiK ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
log10K
ia
D   log10KWTD
  2D E
aji
r
; (2)
SiE ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Eia EWTð Þ2
D E
aji
r
: (3)
Here, KWTD and E
WT respectively denote the dissociation constant and expression level measured
Figure 6. Structural context of mutational effects. (A) Crystal structure (Whitlow et al., 1995) of the CDR1H and
CDR3H variable regions of the WT scFv in complex with fluorescein (green). Each residue (CDR1H: positions 28–
37; CDR3H: positions 100–109) is colored according to the SK and SE values computed for that position. These
variables, SK and SE , respectively quantify the sensitivity of KD and E to amino acid substitutions at each position,
with larger values corresponding to greater sensitivity; see Equations 2 and 3 for definitions of these quantities.
(B,C) For each position in the CDR1H and CDR3H variable regions, SK is plotted against either (B) the number of
contacts the WT residue makes within the protein structure, or (C) the distance of the WT residue to the
fluorescein molecule. (D,E) Similarly, SE is plotted against either (D) the number of contacts or (E) the distance to
the antigen. R2 is the coefficient of determination.
DOI: 10.7554/eLife.23156.023
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for the WT scFv, K iaD and E
ia denote analogous quantities for the scFv with a single substitution muta-
tion of amino acid a at position i, and hiaji denotes an average computed over the 19 non-WT amino
acids at that position.
Figure 6A shows the known structure (Whitlow et al., 1995) of the 1H and 3H variable regions
of the WT scFv in complex with fluorescein. Each residue is colored according to the SK and SE val-
ues computed for its position. To get a better understanding of what aspects of the structure might
govern affinity, we plotted SK values against two other quantities: the number of amino acid contacts
made by the WT residue within the antibody structure (Figure 6B), and the distance between the
WT residue and the antigen (Figure 6C). We found a strong correlation between SK and the number
of contacts, but no significant correlation between SK and distance to antigen. By contrast, SE did
not correlate significantly with either of these structural quantities (Figure 6D and E).
Discussion
We have described a massively parallel assay, called Tite-Seq, for measuring the sequence-affinity
landscape of antibodies. The range of affinities measured in our Tite-Seq experiments (10 9:5 M to
10
 5:0 M) includes a large fraction of the physiological range relevant to affinity maturation (10 10 M
to ~10 6 M) (Batista and Neuberger, 1998; Foote and Eisen, 1995; Roost et al., 1995). Expanding
the measured range of affinities below 10 9:5 M might require larger volume labeling reactions, but
would be straight-forward. Tite-Seq therefore provides a potentially powerful method for mapping
the sequence-affinity trajectories of antibodies during the affinity maturation process, as well as for
studying other aspects of the adaptive immune response.
The details of our Tite-Seq experiments (e.g., 11 antigen concentrations, four sorting bins per
concentration, etc.) were chosen largely for experimental convenience. The effects of varying these
parameters have not been systematically explored, and a future investigation of these effects might
be valuable. Figure 4—figure supplement 8 does illustrate, via simulation, the effect of read depth
on the precision of measured KD values. These simulations, along with an analysis of synonymous
Table 2. Primers. Oligonucleotide sequences are written 50 to 30. Bold sequences indicate variable regions. The ‘1H library’ and ‘3H
library’ primers respectively contained the 1H and 3H variable regions (bold) analyzed in this paper. These primer libraries were synthe-
sized by LC Biosciences using microarray-based DNA synthesis. All other primers were ordered from Integrated DNA Technologies.
The ‘[XX]’ portion of L1AF_XX and L1AR_XX indicates the location of each of 64 different barcodes (i.e., XX = 01, 02, . . ., 64), which
ranged in length from 7 bp to 10 bp and which differed from each other by at least two substitution mutations.
Name Sequence
1H library GTGTTGCCTCTGGATTCACTTTTAGTGACTACTGGATGAACTGGGTCCGCCAGTCTCCAGA
3H library GTGACTGAGGTTCCTTGACCCCAGTAGTCCATACCATAGTAAGAACCCGTACAGTAATAGATACCCAT
oRAL10 TTCTGAGGAGACGGTGACTGAGGTTCCTTG
oRAR10 TGAAGACATGGGTATCTATTACTGTACG
oRAL11 CAGTCCTTTCTCTGGAGACTGGCG
oRAR11 ATGAAACTCTCCTGTGTTGCCTCTGGATTC
3H1F TTCTGAGGAGACGGTGACT
3H2R TGAAGACATGGGTATCTATTACTGTAC
1H2F CAGTCCTTTCTCTGGAGACTG
1H1R ATGAAACTCTCCTGTGTTGCCT
oRA10 GCATATCTAAGGTCTCGTTCTGAGGAGACGGTGAC
oRA11 GCCGATTGTTGGTCTCCATGAAACTCTCCTGTGTTGC
PE1v3ext AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACG
PE2v3 AAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGCT
L1AF_XX ACACTCTTTCCCTACACGACGCTCTTCCGATCT[XX]AGTCTTCTTCAGAAATAAGC
L1AR_XX CTCGGCATTCCTGCTGAACCGCTCTTCCGATCT[XX]GCTTGGTGCAACCTG
DOI: 10.7554/eLife.23156.019
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variants (Figure 4—figure supplement 3), suggest that the primary source of noise in our experi-
ments came not from a lack of sorted cells or Illumina reads, but rather from the inefficient post-sort
recovery of antibody sequences. We therefore suggest that improvements to our post-sort DNA
recovery protocol might substantially improve the resolution of Tite-Seq.
Tite-Seq fundamentally differs from prior DMS experiments in that full binding titration curves,
not two-bin enrichment statistics, are used to determine binding affinities. The measurement of
binding curves provides three major advantages. First, binding curves provide absolute KD values in
molar units, not just rank-order affinities, like those provided by SORTCERY (Reich et al., 2015), or
relative affinity ratios, like those provided by the method of Kowalsky and Whitehead (2016). Sec-
ond, because ligand binding is a sigmoidal function of affinity, DMS experiments performed at a sin-
gle ligand concentration (e.g., [Kowalsky and Whitehead, 2016]) are insensitive to receptor KDs
that differ substantially from this ligand concentration. Binding curves, by contrast, integrate meas-
urements over a wide range of concentrations and are therefore sensitive to a wide range of KDs.
The third advantage of measuring binding curves pertains to the fact that protein sequence
determines not just ligand-binding affinity, but also the quantity and specific activity of surface-dis-
played proteins. Our data (Figure 4—figure supplement 5 and Figure 4—figure supplement 6)
suggest that these confounding effects can be large and that they can distort yeast display affinity
measurements computed from enrichment statistics gathered at a single antigen concentration.
Strong sequence-dependent effects on both the expression and specific activity of yeast-displayed
proteins has been reported by other groups as well (e.g., [Burns et al., 2014]), although the absence
of such effects has also been reported (e.g., [Kowalsky and Whitehead, 2016]). Ultimately, the
magnitude of these effects is likely to vary substantially from protein to protein. It should also be
noted that many DMS studies using yeast display (e.g., epitope mapping studies [Kowalsky et al.,
2015; Doolan and Colby, 2015; Van Blarcom et al., 2015]) might not suffer from these potentially
confounding effects, and in such cases it probably makes sense to employ a simpler experimental
design than is required for Tite-Seq. Nevertheless, either Tite-Seq or other experimental methods
that assay full binding curves are probably essential if one wants to quantitatively and reliably mea-
sure KD values in a massively parallel fashion.
We wish to emphasize, more generally, that changing a protein’s amino acid sequence can be
expected to change multiple biochemical properties of that protein. Our work illustrates the impor-
tance of designing massively parallel assays that can disentangle these effects. Tite-Seq provides a
general solution to this problem for massively parallel studies of protein-ligand binding. Indeed, the
Tite-Seq procedure described here can be readily applied to any protein binding assay that is com-
patible with yeast display and FACS. Many such assays have been developed (Liu, 2015). We expect
that Tite-Seq can also be readily adapted for use with other expression platforms, such as mamma-
lian cell display (Forsyth et al., 2013).
Our Tite-Seq measurements reveal interesting distinctions between the effects of mutations in
the CDR1H and CDR3H regions of the anti-fluorescein scFv antibody studied here. As expected, we
found that variation in and around CDR3H had a larger effect on affinity than did variation in and
around CDR1H. We also found that CDR1H is more optimized for protein expression than is CDR3H,
an unexpected finding that appears to be novel. Yeast display expression levels are known to corre-
late with thermostability (Shusta et al., 1999). Our data is limited in scope, and we remain cautious
about generalizing our observations to arbitrary antibody-antigen interactions. Still, this finding sug-
gests the possibility that secondary CDR regions (such as CDR1H) might be evolutionarily optimized
to help ensure antibody stability, thereby freeing up CDR3H to encode antigen specificity. If this
hypothesis holds, it could provide a biochemical rationale for why CDR3H is more likely than CDR1H
to be mutated in functioning receptors (Liberman et al., 2013) and why variation in CDR3H is often
sufficient to establish antigen specificity (Xu and Davis, 2000).
Tite-Seq can also potentially shed light on the structural basis for antibody-antigen recognition.
By comparing the effects of mutations with the known antibody-fluorescein co-crystal structure
(Whitlow et al., 1995), we identified a strong correlation between the effect that a position has on
affinity and the number of molecular contacts that the residue at that position makes within the anti-
body. By contrast, no such correlation of expression with this number of contacts is observed. Again,
we are cautious about generalizing from observations made on a single antibody. If our observation
were to hold for other antibodies, however, it would suggest that the functional geometry of
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paratopes might be governed by networks of residues whose positions and orientations are strongly
interdependent.
Materials and methods
Tite-Seq was performed as follows. Variant 3H and 1H regions were generated using microarray-syn-
thesized oligos (LC Biosciences, Houston TX. USA). These were inserted into the 4-4-20 scFv of
(Boder and Wittrup, 1997) using cassette-replacement restriction cloning as in (Kinney et al.,
2010); see Appendix 3. Yeast display experiments were performed as previously described
(Boder et al., 2000) with modifications; see Appendix 2. Sorted cells were regrown and bulk DNA
was extracted using standard techniques, and amplicons containing the 1H and 3H variable regions
were amplified using PCR and sequenced using the Illumina NextSeq platform; see Appendix 4.
Three replicate experiments were performed on different days. Raw sequencing data has been
posted on the Sequence Read Archive under BioProject ID PRJNA344711. Low-throughput flow
cytometry measurements were performed on clones randomly picked from the Tite-Seq library.
Sequence data and flow cytometry data were analyzed using custom Python scripts, as described in
Appendices 5 and 6. Processed data and analysis scripts are available at github.com/jbkinney/16_
titeseq.
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Appendix 1
Schematic simulations
For panels D and E of Figure 1, data was simulated (using Equation 1) for two hypothetical
scFvs: one similar to WT, with KD ¼ 1:2 10 9 M, A ¼ 300, and B ¼ 10, and one similar to a
typical mutant, with KD ¼ 10 6 M, A ¼ 1000, B ¼ 10. Simulated sorts were performed at the
eleven antigen concentrations used in our experiments (c ¼ 0 M, 10 9:5 M, 10 9:0 M, . . .,
10
 5:0 M). For each clone at each antigen concentration, fluorescence signals were simulated
for 1000 cells by multiplying the f quantity in Equation 1 by a factor of expðhÞ where h is a
normally distributed random number. Figure 1D shows the mean values of these simulated
fluorescence signals. Curves of the form in Equation 1 were fit to these data by minimizing
the square deviation between predicted log10 f values and the log10 mean of the simulated
fluoresence values. The Tite-Seq measurements illustrated in Figure 1E were simulated by
sorting 1000 cells, using fluorescence values generated in the same manner as above, into
three bins defined by the following fluorescence boundaries: ð0; 30Þ for bin 0, ð30; 300Þ for
bin 1, and ð300;¥Þ for bin 2. The mean bin number for each clone at each antigen
concentration was then computed. Curves having the form in Equation 1 were then fit to
these data by minimizing the square deviation of predicted log10 f values from these mean
bin values.
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Appendix 2
Yeast display
To help ensure consistency across samples, the yeast display cultures used in our low-
throughput flow cytometry measurements and in our Tite-Seq experiments were inoculated
with carefully prepared frozen liquid culture inocula. Specifically, inoculation cultures were
grown at 30C in SC-trp +2% glucose to an OD600 value between 0.9 and 1.1, then stored
at  80 in aliquots containing 10% glycerol and either 0.4 mlOD of cells (for clones) or 1
mlOD of cells (for libraries).
The expression of yeast-displayed scFvs was induced as follows. Liquid cultures of SC-
trp +2% glucose were inoculated using single frozen inocula, yielding an approximate
starting OD of 0.05. These cultures were grown at 30C for 8 hr; the final OD of these
cultures was approximately 0.7. Cells were then spun down at 1932 g for 8 min at 4C,
resuspended in SC-trp +2% galactose+0.1% glucose at 0.2 OD, and incubated for 16 hr at
20
C. We note that adding 0.1% glucose to these galactose induction cultures was essential
for reliably achieving scFv expression in a large fraction of yeast cells.
Induced yeast were fluorescently labeled as follows. Galactose induction cultures were spun
down and washed with ice cold TBS-BSA (0.2 mg/ml BSA, 50 mM Tris, 25 mM NaCl, pH 8).
This yielded approximately 5.3 mlOD of cells for Tite-Seq FACS. For antigen binding
reactions, cells were then resuspended in a primary labeling reaction containing 40 ml TBS-
BSA and biotinylated fluorescein (ThermoFisher B1370) at a concentration between 0 M and
10
 5 M, then incubated with shaking for 1 hr at room temperature. Reaction volumes were
large enough to ensure that >
~
10 antigen molecules per scFv were present, assuming ~ 105
scFvs per cell (Boder and Wittrup, 1997). Cells were then washed twice with 40 ml ice cold
TBS-BSA, suspended in a secondary labeling reaction containing 1 ml ice-cold TBS-BSA and
7 g/ml streptavidin R-PE (ThermoFisher S866), and incubated for 30 min at 4C while
shaking. Cells were then spun down and resuspended in ice cold TBS-BSA and saved for
FACS later that day. Expression labeling reactions proceeded in the same manner, except
that the primary labeling reaction contained 1.4 g/ml rabbit anti-c-Myc antibody (Sigma-
Aldrich C3956) in place of the antigen, and the secondary labeling reaction contained 0.8
g/ml BV421-conjugated donkey anti-rabbit antibody (BioLegend 406410) in place of
streptavidin R-PE. The labeling reactions used to filter out improperly cloned scFvs (as
described in Appendix 3) proceeded in the same manner as the expression labeling
reaction, except that 0.8 g/ml mouse anti-HA antibody (Roche 11583816001) was added to
the primary labeling reaction, while 0.4 g/ml APC-conjugated anti-mouse antibody (BD
Biosciences 550826) was added to the secondary labeling reaction. For clonal flow
cytometry measurements, we kept reagent and cell concentrations the same as described
above, but reduced reaction volumes 27-fold. Secondary labeling reactions with streptavidin
R-PE were done at 4 g/ml in 112.5 l. Secondary labeling reactions with 0.8 g/ml BV421-
conjugated donkey anti-rabbit antibody were performed in 60 l.
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Appendix 3
Cloning strategy
Amplicons containing variable CDR1H or CDR3H regions were generated as follows. An
oligonucleotide library containing mutagenized 1H and 3H variable regions (see Table 2)
was generated by LC Sciences using microarray-based synthesis. The specific oligos used are
provided at github.com/jbkinney/16_titeseq. 1H and 3H library oligos were separately
amplified via PCR using primers oRAL10 and oRAR10 (for 1H) or oRAL11 and oRAR11 (for
3H). Oligos containing the WT sequence were amplified from plasmid pCT302 (Boder and
Wittrup, 1997) using primers 1H2F and 1H1R (for the 1H region) or 3H1F and 3H2R (for the
3H region). Overlap-extension PCR using primers oRA10 and oRA11, one oligo library (1H or
3H) and the complementary WT oligo (3H or 1H, respectively), and plasmid pCT302, were
then used to create the iRA11 amplicon library (Figure 2—figure supplement 1A). Note
that each amplicon in this library had mutations only in the 1H variable region or in the 3H
variable region, but not in both of these regions.
The pRA10 cloning vector (Figure 2—figure supplement 1B) was assembled using Gibson
cloning (Gibson et al., 2009) with template plasmids pCT302 (Boder and Wittrup, 1997)
and pJK14 (Kinney et al., 2010). pCT302 is the yeast display expression plasmid containing
the WT scFv. pJK14 contains a ccdB cloning cassette flanked by outward-facing BsmBI
restriction sites. pRA10 closely resembles pCT302, except that it contains the ccdB cassette
from pJK14 in place of the region of the scFv gene that we aimed to mutagenize. Multiple
spurious BsmBI restriction sites present pCT302 were also removed in pRA10. pRA10 was
propagated in Escherichia coli strain DB3.1, which is resistant to the CcdB toxin.
The pRA11 plasmid library (Figure 2—figure supplement 1C) was generated by digesting
pRA10 with BsmBI, digesting the iRA11 amplicon library with BsaI, and subsequent ligation
with T4 DNA ligase. Ligation reactions were desalted and transformed into DH10B E. coli via
electroporation, yielding >
~
10
8 transformants. The 1H and 3H libraries were cloned
separately.
The pRA11 libraries were introduced into the EBY100 strain of Saccharomyces cerevisiae
using high-efficiency LiAc transformation (Gietz and Schiestl, 2007). This yielded >
~
10
5
transformants. To filter out yeast containing improperly cloned scFvs, we induced scFv
expression, immuno-affinity labeled the HA and c-Myc epitopes on the scFv, and used FACS
to recover 8 105   2 106 cells that registered positive for both epitopes. The scFv
induction and labeling procedures used to do this are described in Appendix 2. 144 yeast
clones were picked at random from this library and submitted for low-throughput Sanger
sequencing of the 1H and 3H variable regions of the scFv. Based on preliminary Tite-Seq
experiments, 19 of these clones were then chosen for low-throughput KD measurements.
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Appendix 4
Tite-Seq procedure
The inocula used for our Tite-Seq experiments comprised yeast harboring the 1H and 3H pRA11
plasmid libraries, mixed in equal proportions, and spiked at 0.625% with OPT-containing
yeast (as a positive control) and at 0.625% with D-containing yeast (negative control). Cells
were then grown, induced, and labeled with antigen at eleven different concentrations (0 M,
10
 9:5 M, 10 9:0 M, . . ., 10 5:0 M) as described in Appendix 2.
Each batch of labeled cells was then sorted, using FACS, over a period of approximately 20
min. During FACS, cells were first filtered based on forward scatter and side scatter to help
ensure exactly one live cell per droplet. Cells passing these criteria were sorted into four
bins based on R-PE fluorescence. The fluorescence gates used in these sorts were kept the
same across all antigen concentrations (see Figure 3, Figure 3—figure supplement 1, and
Figure 3—figure supplement 2). Cells were sorted into a rounded 5 ml polypropylene tube
containing 1 ml 2X YPAD media. In our separate Sort-Seq experiments assaying scFv
expression levels, cells were prepared and sorted in the same way, save for the changes to
the labeling reaction described in Appendix 2 and the use of gates on BV421 fluorescence
instead of R-PE fluorescence.
Each of the 48 bins of sorted cells, as well as a sample of unsorted cells, were then
deposited in 5 ml of SC-trp +2% glucose and regrown overnight at 30C. Approximately 25
mlOD of cells were then spun down, resuspended in a lysis reaction containing 200 l of 0.5
mm glass beads, 200 l of Phenol/chloroform/isoamyl alcohol and 200 l of yeast lysis buffer
(10 mM NaCl, 1 mM Tris, 0.1 mM EDTA, 0.2% Triton X-100, 0.1% SDS), and vortexed for 30
min. 200 l of water was added, cells were spun down, and the aqueous layer was
extracted. Four subsequent extractions were performed, the first two using 200 l of
Phenol/chloraform/isoamyl alcohol, the second two using 200 l for chloroform/isoamyl
alcohol. Bulk nucleic acid was then ethanol precipitated and resuspended in 100 l of IDTE
(Integrated DNA Technologies).
Two rounds of PCR were then performed on each of the 49 samples of bulk nucleic acid. In
the first round of PCR, primers L1AF_XX and L2AF_XX were used to amplify the 1H-to-3H
region and to add a bin-specific barcode (numbered XX = 01, 02, . . ., 64) on either end of
the 1H-to-3H region; see Figure 2—figure supplement 1. To keep PCR crossover to a
minimum, only 15 PCR cycles were used. These 49 PCR reactions were then pooled, purified
using a QIAquick PCR purification kit (Qiagen), and used as template for second round of
PCR with primers PE1v3ext and PE2v3. Again, to keep crossover to a minimum, only 25 PCR
cycles were used. This PCR reaction was again purified, mixed with PhiX DNA (at ~ 25%
molarity) and submitted for sequencing using the Illumina NextSeq platform.
Analysis of the resulting sequence data across the three replicate Tite-Seq experiments
revealed that some of the 147 FACS bins were highly under-sampled. This under-sampling
likely resulted from the use of a non-saturating number of PCR cycles prior to pooling. The
different barcodes incorporated into the PCR primers also appear to have affected
amplification efficiency to different extents. To even out the distribution of reads across bins,
we selected the 27 most poorly sampled bins, re-amplified the 1H-to-3H regions in these
bins using primers with different barcodes than before, and submitted the resulting
amplicons for a fourth round of Illumina NextSeq sequencing.
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Appendix 5
Inference of KD from Tite-Seq data
We modeled the binding titration curve of each sequence – i.e., the curve describing how mean
cellular fluorescence depends on antigen concentration – using a non-cooperative Hill
function. Making the dependence on scFv sequence s and antigen concentration c explicit,
Equation 1 of the main text becomes
fsc ¼ As c
cþKD;sþB; (A1)
where fsc denotes the mean fluorescence of cells carrying sequence s and labeled with
antigen at concentration c, B represents the autofluorescence of cells, and was set equal to
the mean fluorescence of cells labeled at 0 M antigen. As is the increase in fluorescence due
to saturation of all surface-displayed scFvs, and KD;s is the dissociation constant for sequence
s. We inferred As and KD;s for all sequences s as follows.
Tite-Seq does not provide direct measurements of the fluorescence fsc. Instead, we
approximated this quantity using a weighted averaged over sorting bins. Specifically, we
assumed that
ln fsc »
X
b
pbjscFbc: (A2)
Here, Fbc is the mean log fluorescence of the cells that were sorted at concentration c into
bin b, and pbjsc is the probability that a cell having sequence s and labeled at concentration c,
if sorted, would be found in bin b. Values for Fbc were computed directly from the FACS
data log. The probabilities pbjsc, by contrast, were inferred from Tite-Seq read counts. These
probabilities are closely related to Rbsc, the number of sequence reads for each sequence s
from bin b at antigen concentration c. This relationship is complicated by additional factors
that arise from variability in sequencing depth from bin to bin. Moreover, because there
were often a small number of reads for any particular sequence in a given bin, it was
necessary in our inference procedure to treat the relationship between pbjsc and Rbsc
probabilistically.
We therefore inferred values for the probabilities pbjsc through the following maximum
likelihood procedure. First, we assumed that the number of reads Rbsc is related to an
‘expected’ number of reads rbsc via a Poisson distribution. The log likelihood of observing a
specific set of read counts Rbsc over all bins b and concentrations c for a given sequence s is
therefore given by
Ls ¼ ln
Y
b;c
1
Rbsc!
rbsc
Rbsce rbsc
" #
: (A3)
The expected number of reads rbsc is, in turn, related to the probability pbjsc via
rbsc ¼ Rbc
Cbc
CcPs pbjsc: (A4)
Here, Rbc ¼
P
s Rbsc is the total number of reads from bin b at antigen concentration c, Cbc is
the number of cells sorted into bin b at antigen concentration c (obtained from the FACS
data log), Cc ¼
P
b Cbc is the total number of cells sorted at concentration c, and Ps is the
fraction of cells in the library with sequence s. The factor RbcCc=Cbc in Equation A4 accounts
Adams et al. eLife 2016;5:e23156. DOI: 10.7554/eLife.23156 24 of 27
Research article Biophysics and Structural Biology
for differences in the depth with which each bin was sequenced. Note: Equation A3
assumes that each final read arose from a different sorted cell. This assumption is clearly
violated if Rbc>Cbc. In cases where this inequality was found to hold, we rescaled all Rbsc !
hRbsc where h ¼ Cbc=Rbc before undertaking further analysis.
For each sequence s, we inferred KD;s, As, Ps, and all probabilities pbjsc by maximizing the
likelihood Ls subject to the constraint that
X
b
pbjscFbc ¼ ln As c
cþKD;sþB
 
(A5)
at every concentration c. Note that, in this procedure, the sorting probabilities pbjsc are not
modeled explicitly as a function of the putative mean fluorescence. Instead, they are inferred
from the data along with the parameters of the non-cooperative Hill function. Doing this
dispenses with the need for a detailed characterization of the noise in the Tite-Seq sorting
procedure. The validity of this procedure is evinced by the analysis of simulated data, shown
in Figure 4—figure supplement 8.
The maximum likelihood optimization problem described above was solved as follows. For
each concentration c, we created a grid of 100 equally spaced points for ln fsc 2 ½F0a, F3a.
For each possible value of fsc, we then used Nelder-Mead optimization of pbjsc to minimize Ls
under the constraint in Equation A5. Akima interpolation was then used to create a function
of the optimized probability p^bjsc as a function of fsc. We then scanned a 321 201 grid of
values for the pair ðKD;s;AsÞ and selected the pair that minimized
LsðKD;s;As; p^bjscðKD;s;AsÞ;Ps
 	
b;c
Þ. We repeated this scan by varying Ps over 95 different
values. The final inferred values for KD;s, As, and Ps were those so found to maximize Ls.
Python code for this inference procedure is provided at github.com/jbkinney/16_titeseq.
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Appendix 6
Inference of KD from flow cytometry experiments on
individual clones
Low-throughput flow cytometry measurements performed on clonal cell populations were used
to measure fsc;flow, the mean fluoresence of cells carrying sequence s and labeled at antigen
concentration c. As for the Tite-Seq inference procedure described in Appendix 5, it was
assumed that fsc;flow could be modeled using the non-cooperative Hill function
Asc=ðcþ KD;sÞ þ B, where As is the increase in mean fluorescence due to fully labeled scFvs of
sequence s, KD;s is the corresponding dissociation constant, and B is background
fluorescence. B was computed from the average fluorescence of clones at 0 M fluorescein.
As and KD;s were then inferred by minimizing the square deviation between measured
ln fsc;flow values and log Hill function predictions, i.e.,
X
c
ln fsc;flow  ln As c
cþKD;sþB
  2
: (A6)
This optimization procedure was performed using a grid search algorithm in which KD;s was
restricted to the interval ½10 10M; 10 3M and As was restricted to the interval ½A^; 100A^ where
A^ denotes the average range of fluorescence values over the 4-to-8 clones assayed per flow
cytometry session.
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Appendix 7
Realistic Tite-Seq simulations
In order to test our analysis pipeline, we simulated realistic Tite-Seq data and analyzed it with
the same scripts that we used on real data. For each sequence s, a KD;s value was randomly
drawn from the interval [10 10 M, 10 4 M] using a uniform distribution in log space, and an As
value was drawn uniformly from a uniform distribution spanning the bulk of experimentally
observed A values. At each of the eleven antigen concentrations c, we then modeled the
distribution of cellular fluorescence using a Gaussian Mixture Model (GMM) in log space.
Specifically, letting x denote log10 cellular fluorescence values, we assumed that the
probability density describing x to be
PscðxÞ ¼ a
s0
ﬃﬃﬃﬃﬃﬃ
2p
p e 
ðx 0Þ2
2s2
0 þ 1 a
s1
ﬃﬃﬃﬃﬃﬃ
2p
p e 
ðx scÞ2
2s2
1 ; (A7)
where a ¼ 0:2 is the fraction of non-expressing cells, 0 ¼ 4:77 and s0 ¼ 1 are the mean and
standard deviation of x values for dark cells, and s1 ¼ 0:5 is the standard deviation of x
values for scFv-expressing cells. The mean x value of scFv-expressing cells, here denoted cs,
was chosen so that the population average of x is given by the Hill function in Equation A1,
i.e., so that
hxiPsc ¼ As
c
cþKD;sþB: (A8)
The left hand side of Equation A8 can be computed analytically using Equation A7. Doing
this and solving for sc gives
sc ¼ ln Asc
cþKD;sþB ae
0þs20=2
 
  lnð1 aÞ s
2
1
2
; (A9)
this is the specific formula we used to compute sc as a function of c, As, and KD;s. Next we
computed exact pbjsc values using
pbjsc ¼
Z bþ
b 
dxPscðxÞ; (A10)
where bþ and b  are the upper and lower fluorescence bounds used for bin b in our Tite-Seq
experiment (replicate number 1). These values were then used to draw read counts Rbsc for
each sequence s values via
Rbsc ~Binomialðn¼ ksRbc;p¼ pbjscÞ; (A11)
where ks is a random variable, uniformly distributed on a log scale between 0:01 and 100,
used to represent noise due to PCR jackpotting. Data thus simulated for WT values of KD
and A are shown in Figure 4—figure supplement 7.
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